• Publications
  • Influence
Inhaled pyrazinamide proliposome for targeting alveolar macrophages
TLDR
PZA-proliposomes were less toxic to respiratory-associated cells, and did not activate AMs to produce inflammatory mediators, including interleukin-1β, tumor necrosis factor-α, and nitric oxide, at a toxic level, suggesting that PZA- Proliposome are potential candidates for pulmonary tuberculosis treatment. Expand
Levofloxacin-Proliposomes: Opportunities for Use in Lung Tuberculosis
TLDR
LEV-proliposomes were less toxic to respiratory-associated cells than LEV, and did not activate AMs to produce inflammatory mediators that included interleukin-1β (IL-1 β), tumor necrosis factor-α (TNF-α), and nitric oxide, which should now be tested as an alternative formulation for delivering LEV to the lower airways. Expand